Full Text View
Tabular View
No Study Results Posted
Related Studies
HuMax-CD20 in Active Rheumatoid Arthritis
This study has been completed.
Study NCT00291928   Information provided by Genmab
First Received: February 14, 2006   Last Updated: September 30, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Rheumatic Arthritis
Additional conditions recognized in this trial
Arthritis
Arthritis, Rheumatoid
Rheumatic Fever
More general conditions related to this trial
Autoimmune Diseases
Bacterial Infections
Connective Tissue Diseases
Gram-Positive Bacterial Infections
Immune System Diseases
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Streptococcal Infections
Interventions listed in this trial
HuMax-CD20
Sponsors listed in this trial
Genmab
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services